CHINA: Major report covers impact of health reforms on China's Pharmaceutical Market

Impact of China's Health Reforms

Publication Date	October 2009
Publisher	VOI Consulting
Product Type	Report
Pages	52
ISBN Number	not applicable
Product Code	VOI00006

CHINA: Major report covers impact of health reforms on China's Pharmaceutical Market

Buy this product or for assistance call +44 20 7060 7474

PDF £120.00$200 | €134

FAX Order above formats by FAX

Summary

Massive reforms are changing the world's fastest growing market By 2013, China's pharmaceutical market will nearly triple in size to become the third largest in the world with sales of $60 billion. Alongside rapid growth, however, the industry is facing major disruptions in the operating environment as the country implements a three year $124 billion health reform that represents just the first wave of systemic changes scheduled to take place over the next decade. Buyer characteristics, the product selection process, pricing, distribution channels, customer geographics and demographics - all of these will be profoundly different in the environment that is emerging under the new health reforms. Industry decision-makers cannot afford to ignore how these changes will affect the world's fastest-growing market.

Content

Major Events
Healthcare System
Pharmaceutical Market
Market Profile and Structure
Market Performance and Forecasts
Impact of 2009-2011 Health Reforms
Regulatory
Approval Procedures
Provisional vs. Final Standards
Pricing
Price Controls and the 2009-2011 Health Reforms
Payment
Generics
R&D / Clinical Trials
Manufacturing
Distribution
Parallel Trade
Patent & Intellectual Property Issues
The Monitoring Period
Provisional vs. Final Standards
Marketing
Marketing Regulations
Marketing Practices
List of Figures
- Figure 1 - General and Health Statistics
- Figure 2 - Population Statistics
- Figure 3 - Pharmaceutical Market Snapshot
- Figure 4 - TCMs, Generics and Brands: Share of Sales 1999-2008
- Figure 5 - Drug Approval Procedures & Timing
- Figure 6 - 2008 Share of Generic Market by Company
- Figure 7 - Clinical Trial Regulatory Approval Process
- Figure 8 - Top 10 Wholesale Distributors 2008